Bulgaria vs Iran, Islamic Republic of: Average cost of multi drug-resistant tuberculosis treatment
Bulgaria
6,271 constant 2022 US$
in 2024
Iran, Islamic Republic of
28,730 constant 2022 US$
in 2022
Bulgaria rank
6th
Iran, Islamic Republic of rank
3rd
Average cost of multi drug-resistant tuberculosis treatment over time
- Bulgaria
- Iran, Islamic Republic of
How they compare
Iran, Islamic Republic of currently reports 28,730 constant 2022 US$ against 6,271 constant 2022 US$ in Bulgaria, a difference of 22,459 constant 2022 US$.
That makes Iran, Islamic Republic of's figure about 4.6 times Bulgaria's.
Across all 5 years both countries report, Iran, Islamic Republic of has been ahead every year.
Bulgaria ranks 6th and Iran, Islamic Republic of ranks 3rd of 92 countries.
Iran, Islamic Republic of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bulgaria | Iran, Islamic Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,490 constant 2022 US$ | 11,726 constant 2022 US$ | 9,236 constant 2022 US$ | Iran, Islamic Republic of |
| 2020s | 3,416 constant 2022 US$ | 20,687 constant 2022 US$ | 17,271 constant 2022 US$ | Iran, Islamic Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Bulgaria or Iran, Islamic Republic of?
- Iran, Islamic Republic of, at 28,730 constant 2022 US$ against 6,271 constant 2022 US$ in Bulgaria as of 2022.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Bulgaria and Iran, Islamic Republic of?
- 22,459 constant 2022 US$, with Iran, Islamic Republic of ahead.
- How many years of comparable data are there for Bulgaria and Iran, Islamic Republic of?
- 5 years are reported by both, from 2018 to 2022.
- How do Bulgaria and Iran, Islamic Republic of rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Bulgaria ranks 6th and Iran, Islamic Republic of ranks 3rd of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.